July 28, 2016
(Wired) – In fact, drug regulators are usually playing catch up to drug users. But next month at the Rio Olympics, officials will roll out a test for a doping method that athletes might not even be using yet—genetic manipulation of the body’s own cellular machinery, or gene doping. “We feel there’s a great risk this novel technology will be used,” says Carl Johan Sundberg, an exercise physiologist at the Karolinska Institute in Sweden who reviewed the new test for the World Anti-Doping Agency. “So we are being proactive for the first time.”
The views, opinions and positions expressed by these authors and blogs are theirs and do not necessarily represent that of the Bioethics Research Library and Kennedy Institute of Ethics or Georgetown University.